Skip to main content
# Title Department Research Member Research Year
151 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
152
.
Department of Pediatric Oncology Dr. Ahmed Mohammed Morsy Hassan 2021
153 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
154 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
155 Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy Department of Pediatric Oncology Rania Taha Mohammed Ahmed 2021
156 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Marwa Tammam Ameen Hammam 2021
157 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2021
158 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
159 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Pathology Saly Salah Abdelhakeem 2021
160 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2021